Understanding immune-checkpoint inhibitory signaling by PD-1 and BTLA

A large class of receptors expressed on the surfaces of lymphocytes, the "immune checkpoints", exhibit the remarkable ability of being able to suppress their, i.e., the lymphocytes' activity. Through the use of antibodies that prevent the receptors binding their ligands, which reverses T-cell inhibition, clinical interventions via the…